BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. (2023)
Attributed to:
EPSRC IRC in Targeted Delivery for Hard-to-Treat Cancers
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1541-7786.mcr-22-0635
PubMed Identifier: 36669126
Publication URI: http://europepmc.org/abstract/MED/36669126
Type: Journal Article/Review
Volume: 21
Parent Publication: Molecular cancer research : MCR
Issue: 5
ISSN: 1541-7786